Abbott Laboratories

ABT · NYSE · USD

$96.81+0.12%+$0.12

Close · October 2, 2026

At a glance

Revenue growth: +5.67%; 2025 vs 2024
Net income growth: −51.32%; 2025 vs 2024
Net margin: 14.7%; 2024: 31.9%

Financial data

Amounts in millions of USD; per-share values in USD; shares in millions.

Income statement · Annual
Item	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016
Total revenue	44,328	41,950	40,109	43,653	43,075	34,608	31,904	30,578	27,390	20,853
Cost of revenue	19,210	18,644	17,919	19,083	18,080	15,003	13,231	12,696	11,490	9,085
Gross profit	25,118	23,306	22,190	24,570	24,995	19,605	18,673	17,882	15,900	11,768
Selling, general and administrative	11,630	11,109	10,385	10,703	11,006	9,591	9,540	9,568	8,804	6,558
Research and development	2,889	2,823	2,619	2,741	2,738	2,420	2,440	2,298	2,183	1,442
Operating income	8,917	7,496	7,220	9,113	9,204	5,462	4,757	3,838	2,938	3,218
EBIT	8,917	7,496	7,220	9,113	9,204	5,462	4,757	3,838	2,938	3,218
EBITDA	12,033	10,714	10,463	12,380	12,742	8,789	7,771	7,116	5,957	4,569
Interest expense	493	559	637	558	533	546	670	826	904	431
Pre-tax income	8,466	7,013	6,664	8,306	8,211	4,968	4,077	2,873	2,231	1,413
Income tax	1,942	-6,389	941	1,373	1,140	497	390	539	1,878	350
Net income	6,524	13,402	5,723	6,933	7,071	4,495	3,687	2,368	477	1,400
Net income to common shareholders	6,500	13,400	5,700	6,905	7,042	4,449	3,666	2,319	344	1,056
Basic EPS	3.73	7.70	3.28	3.94	3.97	2.51	2.07	1.32	0.20	0.71
Diluted EPS	3.72	7.64	3.26	3.91	3.94	2.49	2.06	1.31	0.20	0.71
Average shares (basic)	1,741	1,740	1,740	1,753	1,775	1,773	1,768	1,758	1,740	1,477
Average shares (diluted)	1,748	1,748	1,749	1,764	1,789	1,786	1,781	1,770	1,749	1,483
Dividend per share	2.40	2.24	2.08	1.92	1.82	1.53	1.32	1.16	1.08	1.05